Found: 17
Select item for more details and to access through your institution.
Tissue oxygen saturation predicts response to breast cancer neoadjuvant chemotherapy within 10 days of treatment.
- Published in:
- Journal of Biomedical Optics, 2019, v. 24, n. 2, p. 1, doi. 10.1117/1.JBO.24.2.021202
- By:
- Publication type:
- Article
Performance of the 2-hour Accelerated Diagnostic Protocol Within the American College of Radiology Imaging Network PA 4005 Cohort.
- Published in:
- Academic Emergency Medicine, 2015, v. 22, n. 4, p. 452, doi. 10.1111/acem.12621
- By:
- Publication type:
- Article
Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG‐ACRIN Research Group (ACRIN 6701).
- Published in:
- Journal of Magnetic Resonance Imaging, 2022, v. 56, n. 3, p. 668, doi. 10.1002/jmri.28093
- By:
- Publication type:
- Article
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).
- Published in:
- JAMA Network Open, 2022, v. 5, n. 5, p. e2210331, doi. 10.1001/jamanetworkopen.2022.10331
- By:
- Publication type:
- Article
Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).
- Published in:
- JAMA Network Open, 2021, v. 4, n. 11, p. e2129697, doi. 10.1001/jamanetworkopen.2021.29697
- By:
- Publication type:
- Article
Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 8, p. 1148, doi. 10.1093/neuonc/nou364
- By:
- Publication type:
- Article
Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 7, p. 945, doi. 10.1093/neuonc/not049
- By:
- Publication type:
- Article
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 7, p. 936, doi. 10.1093/neuonc/not044
- By:
- Publication type:
- Article
Pretreatment <sup>18</sup>F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 842, doi. 10.2967/jnumed.115.166934
- By:
- Publication type:
- Article
Coronary Computed Tomography Angiography Compared With Single Photon Emission Computed Tomography Myocardial Perfusion Imaging as a Guide to Optimal Medical Therapy in Patients Presenting With Stable Angina: The RESCUE Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Arterial Properties as Determinants of Left Ventricular Mass and Fibrosis in Severe Aortic Stenosis: Findings From ACRIN PA 4008.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 21, p. 3401, doi. 10.1002/cncr.28833
- By:
- Publication type:
- Article
Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1061502
- By:
- Publication type:
- Article
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 12, p. 1969, doi. 10.1007/s00259-017-3753-x
- By:
- Publication type:
- Article
Pretreatment FDG-PET Metrics in Stage III Non-Small Cell Lung Cancer: ACRIN 6668/RTOG 0235.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 4, p. 1, doi. 10.1093/jnci/djv004
- By:
- Publication type:
- Article
Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.
- Published in:
- 2015
- By:
- Publication type:
- journal article